Using PET-CT to reduce futile thoracotomy rates in non-small-cell lung cancer: A population-based review

Current Oncology

Volumn 21, Issue 6, 2014, Pages e768-e774

  Smoragiewicz, M ^a   Laskin, J ^a   Wilson, D ^a   Ramsden, K ^a   Yee, J ^b   Lam, S ^a   Shaipanich, T ^a   Zhai, Y ^c   Ho, C ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Endobronchial ultrasonography; Endoscopic ultrasonography; Lymphatic metastasis or pathology; Mediastinal staging; Mediastinoscopy; Non small cell lung cancer; Positron emission tomography computed tomography; Thoracotomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; ENDOBRONCHIAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDICAL RECORD REVIEW; NON SMALL CELL LUNG CANCER; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; THORACOTOMY; TUMOR BIOPSY; TUMOR VOLUME; VERY ELDERLY;

EID: 84916223870     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.2125     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Socinski MA, Crowell R, Hensing TE, et al.on behalf of the American College of Chest Physicians. Treatment of non-small cell lung cancer, stage iv: accp evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):277S-89S.
3. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K on behalf of the American College of Chest Physicians. Treatment of non-small cell lung cancer stage i and stage ii: accp evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):234S-42S.
4. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW on behalf of the American College of Chest Physicians. Treatment of non-small cell lung cancer-stage iiia: accp evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):243S-65S.
5. Jett JR, Schild SE, Keith RL, Kesler KA on behalf of the American College of Chest Physicians. Treatment of non-small cell lung cancer, stage iiib: accp evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):266S-76S.
6. Albain KS, Swann RS, Rusch VW, et al.Radiotherapy plus chemotherapy with or without surgical resection for stage iii non-small-cell lung cancer: a phase iii randomised controlled trial. Lancet 2009;374:379-86.
7. Auperin A, Le Pechoux C, Rolland E, et al.Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181-90.
8. Darling GE, Dickie AJ, Malthaner RA, Kennedy EB, Tey R. Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline. Curr Oncol 2011;18:e304-10.
9. Silvestri GA, Gonzalez AV, Jantz MA, et al.Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(suppl):e211S-50S.
10. De Wever W, Vankan Y, Stroobants S, Verschakelen J. Detection of extrapulmonary lesions with integrated pet/ct in the staging of lung cancer. Eur Respir J 2007;29:995-1002.
11. Fischer B, Lassen U, Mortensen J, et al.Preoperative staging of lung cancer with combined pet-ct. N Engl J Med 2009;361:32-9.
12. van Tinteren H, Hoekstra OS, Smit EF, et al.Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the plus multicentre randomised trial. Lancet 2002;359:1388-93.
13. Maziak DE, Darling GE, Inculet RI, et al.Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009;151:221-8,W-48.
14. Annema JT, van Meerbeeck JP, Rintoul RC, et al.Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304:2245-52.
15. Yasufuku K, Pierre A, Darling G, et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142:1393,400.e1.
16. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA on behalf of the American College of Chest Physicians. Invasive mediastinal staging of lung cancer: accp evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:202S-20S.
17. Handy JR Jr, Asaph JW, Skokan L, et al.What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21-30.
18. Wu J, Ho C, Laskin J, et al.The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: oasis—Outcomes and Surveillance Integration System. Stud Health Technol Inform 2013;183:98-103.
19. Oken MM, Creech RH, Tormey DC, et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
20. Detterbeck F. What to do with “surprise” N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 2008;3:289-302.
21. Pignon JP, Tribodet H, Scagliotti GV, et al.on behalf of the lace Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the lace Collaborative Group. J Clin Oncol 2008;26:3552-9.
22. Burdett S, Stewart L on behalf of the port Meta-analysis Group. Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 2005;47:81-3.
23. Burdett SS, Stewart LA, Rydzewska L. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. Cochrane Database Syst Rev 2007;:CD006157.
24. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. on behalf of the European Organisation for Research and Treatment of Cancer-Lung Cancer Group. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage iiia-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-50.
25. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA, et al.Accuracy of helical computed tomography and 18F fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol 2005;23:8348-56.
26. Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M. Improving the inaccuracies of clinical staging of patients with nsclc: a prospective trial. Ann Thorac Surg 2005;80:1207-14.
27. Mohammed N, Grills IS, Wong CY, et al.Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol 2011;99:18-22.